Contrôle de base à Goyang : les prix de 1 clinique

Dr. Wan‑Sung Kim, MD, PhD, is Director of the Thyroid Center and an Associate Professor of Surgery at Myongji Hospital, an educational partner of Hanyang University. He is a breast and thyroid surgeon. He treats cancer and benign disease and focuses on minimally invasive thyroid and adrenal surgery.

Expertise: endoscopic and robotic thyroidectomy (transoral, axillary-areolar), thyroid radiofrequency ablation, ethanol ablation for thyroid lesions, and endoscopic or robotic adrenal tumor surgery.

He previously served as Head of Surgery at Myongji Hospital and Chuncheon Gangnam Hospital. He completed his residency and a breast and thyroid fellowship at Myongji. He holds an MD and MS from Catholic Kwandong University and a PhD from Kangwon National University. He is a member of the Korean Association of Thyroid and Endocrine Surgeons, the Korean Breast Cancer Society, the Korean Surgical Society, and the Korean Surgical Ultrasound Society.

Dr. Min‑Kyung Lee, MD, PhD, is an endocrinologist. She is an Associate Professor and Director of the Clinical Research Institute at Myongji Hospital.

Clinical focus includes diabetes, thyroid disease, osteoporosis, hyperlipidemia, and adrenal and pituitary disorders. She also performs thyroid ultrasound and biopsy.

Her research includes nationwide cohort studies on metabolic syndrome and type 2 diabetes (Scientific Reports 2020;10:2313; Diabetes Res Clin Pract 2020;165:108237). She has also studied weight change and microvascular outcomes (Korean J Intern Med 2021;36(4):932–941).

Professional roles and memberships include the Scientific Committee of the Korean Society of Lipid and Atherosclerosis and Education Secretary of the Korean Society of Cardiometabolic Syndrome. She serves on the PR Committee of the Korean Society for the Study of Obesity. She is a lifetime member of the Korean Endocrine Society, the Korean Diabetes Association, and the Korean Association of Internal Medicine. She is also a member of the Korean Society for Bone and Mineral Research.

Dr. Hwang Ui Seok, MD, PhD, is a cardiologist. He is Director of the Arrhythmia Center at Myongji Hospital and a Clinical Professor of Cardiology. His expertise includes arrhythmias and syncope, radiofrequency catheter ablation, pacemakers and ICDs, and cardiac and vascular interventions. He also treats angina, heart failure, hypertension, and hyperlipidemia.

He earned his MD from Seoul National University. He completed his MS and PhD at the University of Ulsan. He finished his residency at Seoul National University Hospital. He trained as a fellow at Asan Medical Center. He also completed a research fellowship at the Cleveland Clinic in the United States. He previously served as a Clinical Assistant Professor at Severance Hospital, Yonsei University.

He is a member of the Korean Association of Internal Medicine and the Korean Society of Cardiology. His publications include a 2010 Circulation Journal paper on irrigated catheters for AF ablation and a 2007 Atherosclerosis paper on serial IVUS of ruptured plaques.

Le professeur Park Jung-won est un spécialiste coréen de premier plan dans le domaine du carcinome hépatocellulaire, fort de plus de 30 ans d'expérience. Il est directeur du centre du foie et du cancer du foie ainsi que du centre de soins intégrés contre le cancer à l'hôpital Myongji. Il a dirigé l'élaboration des premières directives coréennes sur le carcinome hépatocellulaire en 2003 et a supervisé leurs mises à jour pendant environ 20 ans. Son équipe a validé la radiothérapie par faisceau de protons pour le cancer du foie, comme en témoigne une publication dans le Journal of Hepatology. Il est l'auteur de plus de 200 articles indexés dans le SCI. Il a également contribué à la direction d'essais mondiaux, notamment l'étude CheckMate 9DW de 2025, qui a démontré une amélioration des résultats grâce à l'association nivolumab et ipilimumab pour le carcinome hépatocellulaire non résécable.

MD/PhD, Université nationale de Séoul ; membre de l'Académie nationale de médecine de Corée ; ancien président de l'Association coréenne du cancer du foie ; président du comité des directives coréennes sur le carcinome hépatocellulaire ; distinctions du Premier ministre et du ministre de la Santé ; prix de la recherche médicale Pfizer et prix académique d'oncologie Roche.